The application of the SCORE charts to advanced age males triple the number of high-risk subjects compared to the Framingham function;La aplicación de las tablas del SCORE a varones de edad avanzada triplica el número de sujetos clasificados de alto riesgo en comparacion con la función de Framingham

Medicina Clinica

Volumn 124, Issue 13, 2005, Pages 487-490

  Mostaza, José M ^a   Vicente, Ignacio ^b   Taboada, Manuel ^b   Laguna, Fernando ^a   Echániz, Ana ^a   García Iglesias, Francisca ^a   Lahoz, Carlos ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Centro de Salud Fuencarral   (Spain)

Author keywords

Cardiovascular risk charts; Framingham; SCORE

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; CLASSIFICATION; FEMALE; FRAMINGHAM FUNCTION; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HYPOLIPEMIA; INTERMETHOD COMPARISON; MALE; NORMAL HUMAN; PRACTICE GUIDELINE; RISK ASSESSMENT; SCORE CHART; SCREENING TEST; SEX DIFFERENCE; SPAIN;

EID: 18844395425     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13073561     Document Type: Article

References (10)

1. Anderson KM, Wilson PW, Odell PM, Kännel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991; 83:356-62.
2. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-47.
3. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285: 2486-97.
4. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J. 2000;21:365-70.
5. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovás J, Cordon F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003; 56:253-61.
6. Empana JP, Ducimetiere P, Arveiler D, Ferrieres J, Evans A, Ruidavets JB, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J. 2003;24: 1903-11.
7. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24: 987-1003.
8. Ramos R, Solanas P, Cordón F, Rohlfs I, Elosua R, Sala J, et al. Comparación de la función de Framingham original y la calibrada del REGICOR en la predicción del riesgo coronario poblacional. Med Clin (Barc). 2003;121:521-6.
9. Comité Español Interdisciplinario para la Prevención Cardiovascular. Adaptación española de la guía europea de prevención cardiovascular. Rev Esp Salud Pública. 2004;78435-8.
10. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J. 1997;18:1231-48.